<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03463278</url>
  </required_header>
  <id_info>
    <org_study_id>Blastocyst-AN004</org_study_id>
    <nct_id>NCT03463278</nct_id>
  </id_info>
  <brief_title>The Number of Blastocysts Formed in the Outcome of Freeze All Strategy: CONFETTI Trial, Cumulative Delivery Rate</brief_title>
  <official_title>The Impact of Blastulation Rate in the Outcome of Freeze All Strategy: CONFETTI Trial, Cumulative Delivery Rate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assisting Nature</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assisting Nature</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective study of the blastulation rate in the outcome of the Freeze all strategy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective study of the blastulation rate in women under the age of 40 years following
      Freeze all strategy, according to AMH levels and sperm parameters.

      Study group 1: number of vitrified blastocysts 0-4 Study group 2: number of vitrified
      blastocysts 5-7 Study group 3: number of vitrified blastocysts &gt;7
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2013</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Pregnancy rate according to blastulation rate</measure>
    <time_frame>5 days of embryo culture</time_frame>
    <description>Cumulative Pregnancy rate according to blastulation rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cumulative Live Birth rate according to blastulation rate</measure>
    <time_frame>5 days of embryo culture</time_frame>
    <description>Cumulative Live Birth rate according to blastulation rate</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Pregnancy, Ovarian</condition>
  <arm_group>
    <arm_group_label>0-4 blastocysts</arm_group_label>
    <description>group A: 0-4 blastocysts vitrified</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5-7 blastocysts</arm_group_label>
    <description>group B: 5-7 blastocysts vitrified</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&gt;7 blastocysts</arm_group_label>
    <description>group C: &gt;7 blastocysts vitrified</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Pregnancy Rate</intervention_name>
    <description>The pregnancy and live birth rate according to number of blastocysts formed in our three groups</description>
    <arm_group_label>0-4 blastocysts</arm_group_label>
    <arm_group_label>5-7 blastocysts</arm_group_label>
    <arm_group_label>&gt;7 blastocysts</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women aged 20-39 years old following blastocyst culture after ICSI cycle in Freeze all
        Strategy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  primary infertility

          -  age 20-39 years;

          -  body mass index (BMI) 18-29kg/m2;

          -  regular menstrual cycle of 26-35days,

          -  presumed to be ovulatory;

          -  &gt;1mil/ml spermatozoa;

          -  short antagonist protocol

        Exclusion Criteria:

          -  poor responders;

          -  age ≥40;

          -  TESE sperm;

          -  PGS cycles;

          -  donor oocytes;

          -  donor sperm
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tatiana Chartomatsidou, MSc</last_name>
    <phone>00302310424294</phone>
    <email>embryology@assistingnature.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assisting Nature</name>
      <address>
        <city>Thessaloníki</city>
        <zip>57001</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evaggelos Papanikolaou, MD, PhD</last_name>
      <phone>00302310424294</phone>
      <email>embryology@assistingnature.gr</email>
    </contact>
    <contact_backup>
      <last_name>Robert Najdecki, MD, PhD</last_name>
      <email>rnajdecki@assistingnature.gr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2018</study_first_submitted>
  <study_first_submitted_qc>March 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2018</study_first_posted>
  <last_update_submitted>March 10, 2018</last_update_submitted>
  <last_update_submitted_qc>March 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy, Ovarian</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

